DXCM vs. RMD
Compare and contrast key facts about DexCom, Inc. (DXCM) and ResMed Inc. (RMD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DXCM or RMD.
Key characteristics
| DXCM | RMD | |
|---|---|---|
| YTD Return | 3.45% | 26.45% |
| 1Y Return | 9.33% | -5.55% |
| 3Y Return (Ann) | 11.42% | 5.01% |
| 5Y Return (Ann) | 33.12% | 15.03% |
| 10Y Return (Ann) | 32.70% | 17.49% |
| Sharpe Ratio | 0.23 | -0.19 |
| Daily Std Dev | 40.10% | 39.31% |
| Max Drawdown | -94.61% | -61.60% |
| Current Drawdown | -21.16% | -25.44% |
Fundamentals
| DXCM | RMD | |
|---|---|---|
| Market Cap | $51.05B | $31.88B |
| EPS | $1.54 | $6.51 |
| PE Ratio | 83.36 | 33.33 |
| PEG Ratio | 2.53 | 1.75 |
| Revenue (TTM) | $3.80B | $4.58B |
| Gross Profit (TTM) | $1.88B | $2.39B |
| EBITDA (TTM) | $848.50M | $1.44B |
Correlation
The correlation between DXCM and RMD is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DXCM vs. RMD - Performance Comparison
In the year-to-date period, DXCM achieves a 3.45% return, which is significantly lower than RMD's 26.45% return. Over the past 10 years, DXCM has outperformed RMD with an annualized return of 32.70%, while RMD has yielded a comparatively lower 17.49% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DXCM vs. RMD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DXCM vs. RMD - Dividend Comparison
DXCM has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 0.87%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 0.87% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% | 1.78% |
Drawdowns
DXCM vs. RMD - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than RMD's maximum drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for DXCM and RMD. For additional features, visit the drawdowns tool.
Volatility
DXCM vs. RMD - Volatility Comparison
The current volatility for DexCom, Inc. (DXCM) is 13.19%, while ResMed Inc. (RMD) has a volatility of 19.59%. This indicates that DXCM experiences smaller price fluctuations and is considered to be less risky than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DXCM vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities